Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-054100
Filing Date
2013-10-16
Accepted
2013-10-16 20:43:04
Documents
1
Period of Report
2013-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd392974.html 4  
1 FORM 4 rrd392974.xml 4 4271
  Complete submission text file 0001181431-13-054100.txt   5769
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 971-204-0382
CYTODYN INC (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Mulholland Michael D. (Reporting) CIK: 0001257911 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 131155127